Back to Agenda
Session 2: Staying Ahead of the Curve: FDA OPDP Insights to Strengthen Promotional Compliance
Session Chair(s)
Twyla Mosey, PharmD, RPh
Division Director
FDA, United States
Gain firsthand insights from the FDA’s Office of Prescription Drug Promotion (OPDP) on emerging trends, enforcement priorities, and best practices shaping the future of compliant drug and biologic advertising and promotion.
Have an account?